Breaking News
Sort by:
Top Post
New Mobile Friendly Web Tool With Interactive Dashboard Gives Individuals the Information They Need on Monkeypox in Advance of Attending Gatherings
Summer is a time when many of us are keen to get away, enjoy the […]
FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved its […]
Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight Against Cancer and Other Diseases
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Digital LightCyclerⓇ System, Roche’s first […]
Roche Launches COVID-19 Test That Detects and Differentiates the Emerging Variant of Interest BA.2.75
Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a COVID-19 test for […]
NHS Trials Smart Goggles to Give Nurses More Time With Patients
High tech goggles will be worn by community nurses on home visits to free up […]
Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care
OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the […]
GITAI Develops Inchworm-Type Robotic Arm Extending Both the Capability and Mobility of Space Robots and Completes Proof-of-Concept Demonstration (TRL 3)
GITAI USA Inc. (GITAI), the world’s leading space robotics company, developed the GITAI IN1 (Inchworm One), a […]
CHMP Recommends EU Approval of Roche’s Vabysmo, the First Bispecific Antibody for the Eye, for Two Leading Causes of Vision Loss
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s (EMA) Committee […]
MD Anderson and Obsidian Therapeutics Announce FDA Clearance of IND Application for Novel TIL Therapy Obx-115
The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance […]
KromaTiD Launches dGH™ Cell Prep Kit
KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more